Skip to main content
INGN
NASDAQ Industrial Applications And Services

Inogen Q2 2026: Revenue Climbs 3%, Adjusted EBITDA Turns Positive, Full-Year Outlook Lifted

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.05
Mkt Cap
$163.801M
52W Low
$5.34
52W High
$9.13
52W Position info
13% above low
Off High info
34% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

INGN is trading near its 52-week low of $5.34 (13% above the low) on elevated volume (1.9× avg).

Summary

Inogen's Q2 2026 revenue rose 3% to $95.1M, Adjusted EBITDA swung to a positive $2.4M, and full-year guidance was raised. The 10-Q also reveals a separation agreement with a former executive and ongoing share buybacks.


Key Events · Earnings and Guidance · INGN

  • Q2 Revenue and Profitability

    Total revenue reached $95.1M, a 3% year-over-year increase, fueled by a 5.5% rise in sales revenue. The net loss narrowed to $3.85M from $4.15M a year ago. Adjusted EBITDA came in at $2.4M, a dramatic improvement from negative $1.4M in Q1 2026.

  • Full-Year Guidance Raised

    Citing strong international demand and improved gross margins, management raised its full-year 2026 guidance. The positive results were flagged in the August 6 8-K, but the 10-Q provides the detailed financials and confirms the upgraded outlook.

  • Share Repurchase Program

    During the first half of 2026, the company bought back 1.15M shares for $7.5M at an average price of $6.55. With $22.5M remaining under the $30M authorization, the board is signaling confidence in the stock's value.

  • Executive Separation Agreement

    A separation agreement with former executive Michael Bourque, effective July 1, 2026, is included in the 10-Q. The terms provide 12 months of base salary continuation and COBRA reimbursement, replacing prior severance arrangements.


Analysis · INGN · Industrial Applications And Services

A solid second quarter saw Inogen return to revenue growth and positive Adjusted EBITDA, prompting a raise in full-year guidance — a sharp reversal from the prior quarter's negative EBITDA. The filing also details a separation agreement with a former executive and ongoing share repurchases, underscoring management's confidence in the balance sheet. While the recent 8-K previewed the positive momentum, the 10-Q delivers the complete financial picture along with new disclosures on equity grants and insider departures.

At the time of this filing, INGN was trading at $6.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $163.8M. The 52-week trading range was $5.34 to $9.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Aug 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $6.05 info
Change: -$0.050 (-0.82%) info
Market Cap: $163.801M info
INGN
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.38
Real-time Price: $6.05 info
Change: -$0.3334 (-5%) info
Market Cap: $163.801M info
INGN
Jul 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $6.05 info
Change: -$0.650 (-10%) info
Market Cap: $163.801M info
INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $6.05 info
Change: -$0.080 (-1%) info
Market Cap: $163.801M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $6.05 info
Change: -$0.970 (-14%) info
Market Cap: $163.801M info